BULLETIN DU CANCER, cilt.107, sa.1, 2020 (SCI-Expanded)
Hepatobiliary complications ore frequent in the context of ollogeneic hematopoietic cell transplantation (allo-HCT) and contribute largely to the morbidity and mortality after transplantation. Within the framework of the ninth workshops of practice harmonization of the Francophone Society of Bone Morrow Transplantation and Cellular Therapy (SFGM-TC) held in Lille in September 2018, diagnostic approaches and treatments of hepatobiliory dysfunctions prior to and following transplantation were reviewed according to the analysis of published studies.